Home > Healthcare > Drug Device Combination > Therapeutic Systems > Androgenetic Alopecia Treatment Market

Androgenetic Alopecia Treatment Market Size

  • Report ID: GMI9219
  • Published Date: Apr 2024
  • Report Format: PDF

Androgenetic Alopecia Treatment Market Size

Androgenetic Alopecia Treatment Market size was valued at around USD 2.8 billion in 2023 and is estimated to grow at 7.6% CAGR from 2024 to 2032. The increasing incidence of androgenetic alopecia is fueled by various factors such as changing lifestyle patterns, genetic predisposition, and hormonal imbalances, all contributing significantly to the market growth. For instance, the National Library of Medicine states that androgenetic alopecia affects up to 50 million men in the U.S.

 

Furthermore, the increasing prevalence of chronic diseases associated with hair loss is a significant factor driving the demand for market. The condition is often associated with chronic diseases such as diabetes, hypertension, asthma, and polycystic ovarian syndrome (PCOS). For instance, the prevalence of hypertension in the U.S. in 2021 was 49.6% corresponding to 115 million persons. Hence, the market is expected to grow significantly in the coming years due to the rising incidence of these conditions and the increasing demand for effective solutions to address hair loss concerns.
 

Androgenetic alopecia treatment refers to interventions aimed at managing androgenetic alopecia, a common form of hair loss characterized by a genetic predisposition and hormonal influences. The treatment aims to slow down hair loss, promote hair regrowth, and improve overall hair density and appearance.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Androgenetic alopecia treatment market size was valued at USD 2.8 billion in 2023 and is estimated to grow at 7.6% CAGR from 2024 to 2032, driven by changing lifestyle patterns and genetic predisposition.

The pharmaceutical treatment type segment reached USD 1.4 billion in 2023 and will grow rapidly till 2032, owing to its effectiveness in slowing down hair loss.

North America androgenetic alopecia treatment market accounted for USD 943 million in revenue in 2023 and will grow rapidly till 2032, driven by the growing awareness of androgenetic alopecia treatment options.

Apira Science, Inc. (iGROW Laser), Aurobindo Pharma, Cipla, Inc., Curallux, LLC, Dr. Reddy’s Laboratories Ltd., Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System), Johnson & Johnson Services, Inc., Lexington Intl., LLC, and Merck & Co., Inc. among others.

Androgenetic Alopecia Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 213
  • Countries covered: 23
  • Pages: 110
 Download Free Sample